ArticleMaterials today. Bio2026
Triple-helical ligands for collagen-binding proteins improve cartilage extracellular matrix production in nasal chondrocytes.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of articular chondrocytes for cartilage repair is constrained by donor-site morbidity, poor proliferation, and difficulties to maintain a stable phenotype. As a result, nasal chondrocytes (NCs) have recently emerged as an alternative cell source. To better establish the potential of NCs in tissue engineering, we have explored their response to the activation of collagen-binding proteins (integrins, discoidin domain receptors (DDRs) andthe secreted protein acidic cysteine-rich (SPARC)) which are essential to cartilage homeostasis. Ligands for these proteins were synthesized as triple-helical peptides (THPs) that mimic the biological and structural properties of collagen, and were covalently linked to PEG or alginate hydrogels hosting human NCs. Compared to human adipose-tissue mesenchymal stem cells, NCs over-expressed chondrogenic markers, yielding higher Sox9 translocation and type II collagen production. THP ligands significantly improved the expression of key cartilage extracellular matrix components in hydrogels, at both the RNA and protein level, for up to 21 days of culture. In particular, THP ligands for DDRs and SPARC led to increased glycosaminoglycan and collagen deposition. In addition, THPs limited fibrocartilage formation, matrix metalloproteinase 13 expression and chondrocytes hypertrophy after 7 days of culture in hydrogels. This work introduces a biomimetic strategy to drive the early stages of the formation of an engineered cartilage tissue from NCs, by replicating key cell/collagen interactions. It provides a preliminary effort to combine an accessible cell source with functionalized biomaterials for cartilage repair.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.